Healthcare products company West Pharmaceutical Services (NYSE:WST) reported in Q2 CY2025, with sales up 9.2% year on year to ...

West Pharmaceutical Services stock was soaring Thursday after the maker of injectable medicines reported better-than-expected ...

Medical equipment maker West Pharmaceutical raised its annual profit forecast on Thursday, after topping second-quarter estimates on robust demand for its components used in GLP-1 weight-loss and ...

For the year, West Pharmaceutical now expects adjusted per-share earnings of $6.65 to $6.85, up from a prior outlook of $6.15 to $6.35. The company raised its sales outlook to $3.04 billion to $3.06 ...

The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...

With U.S. stock markets set to open in two hours, West Pharmaceutical Services Inc. (WST) was up 17.6% in pre-market trading, and Icon PLC (ICLR) was up 16.1%.

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

Gov. Glenn Youngkin says he has a deal for a multi-billion-dollar pharmaceutical factory in Virginia, but he doesn't have a ...

Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center ...